OR2H1 is an effective target for CAR T cells in human epithelial tumors
Research Grant
Administered By
Integrative Immunobiology
Awarded By
National Institutes of Health
Start Date
August 1, 2023
End Date
July 31, 2025
Administered By
Integrative Immunobiology
Awarded By
National Institutes of Health
Start Date
August 1, 2023
End Date
July 31, 2025